GL1X · GenesisL1 explorer

Research workbench

P01185: AlphaFold monomer V2.0 prediction for vasopressin-neurophysin 2-copeptin (P01185)

Analyse P01185: AlphaFold monomer V2.0 prediction for vasopressin-neurophysin… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
P01185
Type
protein
Length
164 residues
Chains
1
Deposited
01-JUL-21
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x7c75F0f7d6d136A2b8D4C6C6e9b3D8a697949DF1
Molecule
Vasopressin-neurophysin 2-copeptin
UniProt
P01185
Pockets
2 · best druggability 0.39

Structure

1 distinct chain · 36% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVasopressin-neurophysin 2-copeptinprotein16436% helix, 18% strandP01185

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11180.390.7521empty
2740.330.7516empty

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 7KH0 · Cryo-EM structure of the human arginine vasopressin AVP-vasopressin receptor V2R-Gs… · an experimental structure of the same protein · chain A against L, TM-score 0.04
  • 7KH0 · Cryo-EM structure of the human arginine vasopressin avp-vasopressin receptor V2R-gs… · an experimental structure of the same protein · chain A against L, TM-score 0.04

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.